Adaptive Biotechnologies Corp's President and COO, Julie Rubinstein, reported exercising stock options for 44,166 shares at $8.46 and selling 57,180 s...
Neutral
Adaptive Biotechnologies President and COO Julie Rubinstein sold 57,180 shares of ADPT stock for approximately $826,251 between April 14 and April 16,...
Adaptive Biotechnologies' President and COO, Julie Rubinstein, exercised stock options for 44,166 shares at $8.46 per share and subsequently sold 57,1...